News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery
Lunai Bioworks launches platform embedding risk intelligence into AI pipelines for faster therapeutic development and biodefense. The solution safeguards against misuse of generative AI -
COMMUNIQUÉ DE PRESSE
Insolvency EVAN Group PLC ISIN: DE000A19L426 / WKN: A19L42 - GÖRG RECHTSANWÄLTEGEMEINSCHAFT
Swiss Merchant Group AG files claim for financial damage due to incorrect insolvency application by law firm GÖRG Rechtsanwälte Gemeinschaft for EVAN Group PLC. Board to stand for election as bondholders' representative -
-
COMMUNIQUÉ DE PRESSE
1933 Industries Closes Repurchase and Cancellation of Convertible Debentures
1933 Industries Inc. closes Debenture Repurchase Agreement, repurchasing $475,000 in principal value for $47,500 CAD, removing outstanding liabilities. Agreement conducted in accordance with trust indenture and securities laws -
COMMUNIQUÉ DE PRESSE
NanoViricides to Present at the Life Science Executive Partnering (LSX) Congress in Boston on September 17, 2025
NanoViricides, Inc. to showcase revolutionary antiviral drug NV-387 at LSX World Congress 2025 in Boston. Update on drug pipeline and platform technologies by Dr. Diwan